Renal Resistance Trend During HMP Is More Predictive of Postoperative Outcome Than Biopsy Score

Clinical Evidence

Renal Resistance Trend During HMP Is More Predictive of Postoperative Outcome Than Biopsy Score

Renal Resistance Trend During HMP Is More Predictive of Postoperative Outcome Than Biopsy Score

Bissolati et al. sought evaluate the prognostic role of renal resistance (RR) valued during hypothermic machine perfusion (HMP) on postoperative outcome. They analyzed 65 kidneys that were preserved using HMP from DCD and ECD donors.

They found:

  • Kidneys that reached an acceptable RR in the first 60 min of perfusion had better outcomes 
  • Kidneys that did not reach an acceptable RR in the first 60 min of perfusion had primary non function (PNF) and delayed graft function (DGF).

Overall, they found that biopsy score did not correlate with PNF/DGF rate. However, they found that RR trend during HMP seemed to be a better predictor of post-transplantation outcomes. They concluded that RR trend during HMP can predict post-transplant outcomes, especially in regard to ECD donors.

Read the full article here: https://doi.org/10.1111/aor.13117

Tagged In:

DGF, HMP, Kidney, PNF, Renal Resistance

The Latest

Check out the most recent posts

Katie, Strategic Account Manager

Katie, Strategic Account Manager

My connection to donation and transplantation began with my uncle’s heart transplant in 2002. Since 2011, I’ve served the field through roles in organ procurement, transplant nursing, service line leadership, and industry support for diagnostics and immunosuppressive...

Perspective: One Mission, Many Stories

Author: Virginia Liuti, Strategic Account Manager July 22, 2026As we approach World Organ Donation Day on August 13, I have been reflecting on my own journey in healthcare and how it has shaped the way I see our transplant community. Before joining Organ Recovery...

Ruthanne, Manager, Medical Affairs

Ruthanne, Manager, Medical Affairs

With nearly 30 years of experience in organ transplantation and donation, I joined ORS in April 2024. In my current role as Manager of Medical Affairs, I translate clinical insights into actionable guidance, ensure clear and credible scientific communication across...